Filing Details
- Accession Number:
- 0001127602-12-024600
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-16 16:18:34
- Reporting Period:
- 2012-08-15
- Filing Date:
- 2012-08-16
- Accepted Time:
- 2012-08-16 16:18:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1018538 | R Gail Wilensky | C/O Quest Diagnostics Incorporated 3 Giralda Farms Madison NJ 07940 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-08-15 | 20,000 | $30.46 | 33,952 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-08-15 | 20,000 | $59.24 | 13,952 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2012-08-15 | 20,000 | $0.00 | 20,000 | $30.46 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-05-13 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $59.19 to $59.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The options vested in three annual installments beginning with the first on May 13, 2004, the second on May 13, 2005 and the final on May 13, 2006.